One of these days we’ll be saying good bye to our old friend vanco. Until then, here is a new consensus statement for optimal use of a dying drug. Although there has been extensive published experience with vancomycin there are few available prospective randomized trials. Thus, this consensus statement draws heavily on “lower level” evidence.
The document is available as free full text. It is an excellent review of vancomycin use and deserves to be read in the original. Any highlights I would post here would not do it justice.